| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 102,628 | 81,267 | 77,399 | 76,500 | | Cost of Revenue | 11,895 | 9,959 | 6,812 | 8,948 | | | Gross Profit | 90,733 | 71,308 | 70,587 | 67,552 | | | Operating Expenses | | Research Development | 21,323 | 19,089 | 15,275 | 14,872 | | Selling General and Administrative | 41,523 | 36,652 | 38,789 | 32,066 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,887 | 15,567 | 16,523 | 20,614 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (125) | (90) | 657 | 132 | | Earnings Before Interest And Taxes | 27,762 | 15,477 | 17,180 | 20,746 | | Interest Expense | 80 | 333 | 432 | 643 | | Income Before Tax | 27,682 | 15,144 | 16,748 | 20,103 | | Income Tax Expense | 951 | 638 | 1,412 | 415 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,731 | 14,506 | 15,336 | 19,688 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,731 | 14,506 | 15,336 | 19,688 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,731 | $14,506 | $15,336 | $19,688 |
|
0.51% Nasdaq 
Income Statement
